Published in Mol Cell Oncol on July 15, 2014
Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT). PLoS One (2017) 0.75
TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs. J Leukoc Biol (2017) 0.75
Epstein-Barr virus: 40 years on. Nat Rev Cancer (2004) 9.70
A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest (2007) 8.54
Nasopharyngeal carcinoma. Lancet (2005) 7.16
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol (2008) 6.62
The many substrates and functions of ATM. Nat Rev Mol Cell Biol (2000) 5.46
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature (2009) 5.46
Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol (2002) 5.00
The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J (1995) 4.26
TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell (2009) 3.38
Focus on nasopharyngeal carcinoma. Cancer Cell (2004) 3.17
ATM activation and DNA damage response. Cell Cycle (2007) 2.81
Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol (2011) 2.45
Extrinsic regulation of pluripotent stem cells. Nature (2010) 2.39
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells (2004) 2.37
The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol (1996) 2.28
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med (2012) 2.24
LMP1 structure and signal transduction. Semin Cancer Biol (2001) 1.85
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood (2007) 1.83
Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 1.78
Functions and regulation of the 70kDa ribosomal S6 kinases. Int J Biochem Cell Biol (2010) 1.70
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature (2008) 1.52
The unsolved enigmas of leukemia inhibitory factor. Stem Cells (2003) 1.48
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J (2003) 1.47
Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol (2008) 1.33
ATM, a central controller of cellular responses to DNA damage. Cell Death Differ (2001) 1.33
Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol (2009) 1.31
Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells (1999) 1.29
Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol (2007) 1.28
Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev (2000) 1.28
Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res (2007) 1.23
Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol Cell Physiol (2002) 1.23
CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal (2003) 1.22
Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol (2010) 1.22
Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix. J Cell Biol (1993) 1.20
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest (2013) 1.19
Links between innate immunity and normal tissue radiobiology. Radiat Res (2010) 1.19
Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem (2001) 1.17
Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod (2002) 1.16
Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol (2005) 1.14
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem (2000) 1.05
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor. Breast Cancer Res Treat (2012) 1.03
Leukemia inhibitory factor and interleukin-11: critical regulators in the establishment of pregnancy. Cytokine Growth Factor Rev (2009) 1.02
Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors (2001) 1.00
LIF-dependent signaling: new pieces in the Lego. Stem Cell Rev (2012) 0.98
Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression. Int J Oncol (2007) 0.98
Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int J Cancer (1996) 0.97
The impact of leukemia inhibitory factor in uterine flushing on the reproductive potential of infertile women--a prospective study. Am J Reprod Immunol (2007) 0.96
A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages. Hum Pathol (2001) 0.95
Review: LIF and IL11 in trophoblast-endometrial interactions during the establishment of pregnancy. Placenta (2010) 0.93
Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array. Cancer Lett (2009) 0.93
Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon Cytokine Res (1995) 0.91
Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor. Int J Oncol (2007) 0.90
Cytokine signaling and Epstein-Barr virus-mediated cell transformation. Cytokine Growth Factor Rev (2001) 0.89
The LIF cytokine: towards adulthood. Eur Cytokine Netw (2009) 0.89
Role of LMP1 in immune control of EBV infection. Semin Cancer Biol (2001) 0.87
Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. J Clin Endocrinol Metab (1998) 0.87
The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation. Protein Cell (2012) 0.86
Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways. Cell Signal (2010) 0.85
LIF-STAT signaling and trophoblast biology. JAKSTAT (2013) 0.84
Cytokines, thyroid diseases and thyroid cancer. Cytokine (2010) 0.82
The Role of the Leukemia Inhibitory Factor (LIF) - Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells. Genes (Basel) (2011) 0.82
Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs. Mol Biol Cell (2000) 0.82
LIF and the heart: just another brick in the wall? Eur Cytokine Netw (2013) 0.82
Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines. J Immunol (1999) 0.82
Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Neurosci (2011) 0.79
Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA. Comp Hepatol (2004) 0.79
In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. J Clin Endocrinol Metab (1999) 0.77
The effect of serum concentration of leukaemia inhibitory factor on in vitro fertilization treatment outcome. Am J Reprod Immunol (2006) 0.76
Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics. Histopathology (2008) 0.76